Compugen 股票：在 MAIA 分析前拥有更佳的资金跑道 (NASDAQ:CGEN)
· seekingalpha.com
Compugen (CGEN) 股票直至 2029 年的现金跑道提升了 MAIA 中期分析前的风险回报比。阅读此处获取详细投资分析。
Compugen Ltd. ( CGEN ) is an immuno-oncology company that uses its Unigen platform to identify novel immune targets and translate them into antibody therapies. ...